Jan. 30, 2006 — The European Commission has approved an inhalable formulation of recombinant human insulin for the treatment of adults with diabetes mellitus, and 10% intravenous immune globulin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results